Patricia L. Allen
Director at Zenas Biopharma · 4 reported transactions in 1 company · latest trade Feb 13, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +23.2%, S&P 500 +12.8% over the same days.
Their trades
Bought | Feb 13, 2026 | Feb 13, 2026 close $26.40 → Oct 29, 2026 close $28.97. S&P 500 +13.3% over the same days. | ||
Bought | Feb 12, 2026 | Feb 12, 2026 close $26.11 → Oct 29, 2026 close $28.97. S&P 500 +13.4% over the same days. | ||
Bought | Feb 12, 2026 | Feb 12, 2026 close $26.11 → Oct 29, 2026 close $28.97. S&P 500 +13.4% over the same days. | ||
Bought | Feb 12, 2026 | Feb 12, 2026 close $26.11 → Oct 29, 2026 close $28.97. S&P 500 +13.4% over the same days. |
BoughtZenas Biopharma
$109.7K
Feb 13, 2026 close $26.40 → Oct 29, 2026 close $28.97. S&P 500 +13.3% over the same days.
BoughtZenas Biopharma
$132.5K
Feb 12, 2026 close $26.11 → Oct 29, 2026 close $28.97. S&P 500 +13.4% over the same days.
BoughtZenas Biopharma
$138.7K
Feb 12, 2026 close $26.11 → Oct 29, 2026 close $28.97. S&P 500 +13.4% over the same days.
BoughtZenas Biopharma
$118.8K
Feb 12, 2026 close $26.11 → Oct 29, 2026 close $28.97. S&P 500 +13.4% over the same days.